Post cessation of a distribution agreement with a third party distributor, bare metal stents (bms) and drug eluting stents (des) units were returned from the distributor to medtronic.Subsequent processes within medtronic detected issues with the product carton material and carton label content, suggesting that in some instances, replacement of the product carton material and carton labels had been carried out by the third party distributor.There are no units impacted in the us market.For this event, it was reported that a clinician requested a resolute integrity drug eluting stent.The clinician took the box, opened it and removed the product from the inner pouch.The device was implanted.The sticker from the inner pouch was placed in the procedural notes.The sticker was for the same size integrity bare metal stent device (therefore implanting a bms when they had requested a des).
|